[go: up one dir, main page]

TR200003157T2 - Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler - Google Patents

Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler

Info

Publication number
TR200003157T2
TR200003157T2 TR2000/03157T TR200003157T TR200003157T2 TR 200003157 T2 TR200003157 T2 TR 200003157T2 TR 2000/03157 T TR2000/03157 T TR 2000/03157T TR 200003157 T TR200003157 T TR 200003157T TR 200003157 T2 TR200003157 T2 TR 200003157T2
Authority
TR
Turkey
Prior art keywords
lamivudine
zidovudine
pharmaceutical compositions
compositions containing
abacavir
Prior art date
Application number
TR2000/03157T
Other languages
English (en)
Turkish (tr)
Inventor
Currie Robin
Jain Sunil
Wayne Wood Allen
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200003157T2 publication Critical patent/TR200003157T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR2000/03157T 1998-04-29 1999-04-26 Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler TR200003157T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809213.3A GB9809213D0 (en) 1998-04-29 1998-04-29 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TR200003157T2 true TR200003157T2 (tr) 2001-01-22

Family

ID=10831228

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03157T TR200003157T2 (tr) 1998-04-29 1999-04-26 Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler

Country Status (23)

Country Link
EP (1) EP1083932A1 (pt)
JP (1) JP2002512979A (pt)
KR (1) KR20010043128A (pt)
CN (1) CN1411380A (pt)
AP (1) AP2000001971A0 (pt)
AU (1) AU4135599A (pt)
BR (1) BR9910071A (pt)
CA (1) CA2330391A1 (pt)
EA (1) EA200000997A1 (pt)
EE (1) EE200000646A (pt)
GB (1) GB9809213D0 (pt)
HR (1) HRP20000732A2 (pt)
HU (1) HUP0101622A3 (pt)
ID (1) ID26955A (pt)
IL (1) IL139181A0 (pt)
IS (1) IS5675A (pt)
NO (1) NO20005418L (pt)
NZ (1) NZ507745A (pt)
PL (1) PL343710A1 (pt)
SK (1) SK16212000A3 (pt)
TR (1) TR200003157T2 (pt)
WO (1) WO1999055372A1 (pt)
ZA (1) ZA200005922B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
BR0215707A (pt) * 2002-04-23 2005-05-03 Lupin Ltd Composição farmacêutica para a liberação controlada de ingredientes ativos e processo para a preparação de uma composição farmacêutica
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
CN100335125C (zh) * 2003-06-03 2007-09-05 上海现代药物制剂工程研究中心 杀毒抗菌用长效干扰素喷鼻粉剂
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
WO2007013047A2 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) * 2005-11-10 2008-06-01 Combino Pharm, S.L. Formulaciones orales que comprenden 3'-azidonucleosidos.
CN101878032A (zh) * 2007-10-02 2010-11-03 埃默里大学 齐多夫定和针对hiv聚合酶中k65r突变选择的药剂的强力组合
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
SMT201800290T1 (it) * 2010-01-27 2018-07-17 Viiv Healthcare Co Terapia antivirale
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
IN2014MN01907A (pt) 2012-03-05 2015-07-10 Cipla Ltd
NZ706223A (en) 2012-10-23 2018-11-30 Cipla Ltd Pharmaceutical antiretroviral composition
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JP2002512979A (ja) 2002-05-08
CN1411380A (zh) 2003-04-16
HUP0101622A3 (en) 2003-09-29
SK16212000A3 (sk) 2001-07-10
EA200000997A1 (ru) 2001-06-25
HRP20000732A2 (en) 2001-02-28
NO20005418D0 (no) 2000-10-27
AP2000001971A0 (en) 2000-12-31
ID26955A (id) 2001-02-22
HUP0101622A2 (hu) 2002-03-28
IS5675A (is) 2000-10-20
NZ507745A (en) 2004-07-30
IL139181A0 (en) 2001-11-25
AU4135599A (en) 1999-11-16
GB9809213D0 (en) 1998-07-01
EE200000646A (et) 2002-04-15
NO20005418L (no) 2000-11-29
PL343710A1 (en) 2001-08-27
ZA200005922B (en) 2001-10-23
CA2330391A1 (en) 1999-11-04
KR20010043128A (ko) 2001-05-25
BR9910071A (pt) 2000-12-26
EP1083932A1 (en) 2001-03-21
WO1999055372A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
TR200003157T2 (tr) Abacavir, lamivudin ve zidovudin içeren homojen farmasötik bileşimler
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
DK1126828T3 (da) Oral indgivelse af adenosin-analoger
MXPA02006679A (es) Composicion farmaceutica.
NZ333707A (en) Antiviral compositions comprising Aeginetiae herba derived from plant extracts and at least one other Chinese herbal medicine
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
BR0210350A (pt) Nucleosìdeos 4'-substituìdos
RU94013464A (ru) Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
ES2177695T3 (es) Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral.
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
ES2179110T3 (es) Succinato 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral.
EA199900345A1 (ru) Фармацевтические композиции, содержащие ламивудин и зидовудин
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
IE893991L (en) 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition
PA8449301A1 (es) Composiciones farmaceuticas
ES2064748T3 (es) Composiciones antiviricas conteniendo derivados del sulfoquinovosil glicerol y analogos del mismo y su uso.
MX9700044A (es) Combinacion triple anti-virus de inmunodeficiencia humana.
BR9710206A (pt) Uso de um agente de interleucina-8 e formulação farmacéutica antiviral
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
DE69807129D1 (de) Verwendung einer Kombination von beta-Sitosterol und beta-Sitosterol-Glukosid zur Herstellung eines Medikamentes zur Behandlung von HIV-Infektion